DVT Prevention in Astronauts During Spaceflight

Direct Recommendation

• The American College of Chest Physicians recommends implementing frequent active lower extremity exercises combined with properly fitted below-knee graduated compression stockings (15-30 mmHg at ankle) for astronauts during spaceflight, while avoiding routine pharmacologic thromboprophylaxis unless additional high-risk factors are present 1, 2

Prevention Strategy Algorithm

Primary Prevention Measures

• Below-knee graduated compression stockings (15-30 mmHg pressure at ankle) should be worn during periods of prolonged immobility to reduce DVT risk by maintaining venous flow despite loss of gravitational gradient 1, 2
• Adequate hydration (increase fluid intake by 0.5-1 liter per day) helps prevent volume depletion that could exacerbate venous stasis 3, 4

What NOT to Use

• Aspirin and routine anticoagulation are not recommended for DVT prophylaxis in astronauts without additional risk factors, as they lack evidence for VTE prevention and cause major bleeding in 5 per 1,000 patients annually 1, 2

Risk Stratification for Enhanced Prophylaxis

High-Risk Astronauts Requiring Pharmacologic Prophylaxis

• Consider prophylactic low-molecular-weight heparin (LMWH) in weight-adjusted dosing for astronauts with a history of prior VTE, active malignancy, known thrombophilic disorder, or recent surgery or trauma 1, 5

Additional Risk Factors in Female Astronauts

• Women using oral contraceptives or hormone replacement therapy face substantially elevated risk (8.2-fold increased VTE risk with combined spaceflight and HRT) and may require consideration of alternative contraceptive methods or enhanced prophylaxis 6

Critical Caveats

• The evidence base for spaceflight-specific DVT prevention remains limited, and current recommendations extrapolate from terrestrial long-haul travel data, where baseline symptomatic VTE risk is approximately 1 per 4,600 flights >4 hours 2, 6